Amblyomin-X

N/A

Report date: 2023/05/22 10:16:32

Base Information

Drug NameAmblyomin-X
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionApoptosis stimulantsFactor Xa inhibitors
TargetsCoagulation factor X
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBrazil
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A